| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 12.073 | 27.896 | 30.383 | 44.107 | 54.811 | 58.506 | 48.590 |
| Total Income - EUR | - | - | 0 | 47.583 | 27.966 | 30.960 | 44.107 | 54.811 | 58.506 | 48.590 |
| Total Expenses - EUR | - | - | 5.616 | 29.732 | 27.194 | 27.102 | 34.097 | 42.106 | 47.806 | 46.637 |
| Gross Profit/Loss - EUR | - | - | -5.616 | 17.850 | 772 | 3.859 | 10.010 | 12.705 | 10.700 | 1.953 |
| Net Profit/Loss - EUR | - | - | -5.616 | 17.730 | 492 | 3.561 | 9.569 | 12.188 | 10.156 | 803 |
| Employees | - | - | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Neuroviva Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 12.170 | 35.437 | 28.109 | 18.821 | 9.932 | 62.333 | 47.315 | 36.691 |
| Current Assets | - | - | 7.993 | 2.462 | 5.105 | 6.135 | 19.941 | -10.159 | -4.795 | 10.630 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 5.318 | 0 | 0 | -21 | 18 | 15 | 0 | 50 |
| Cash | - | - | 2.675 | 2.462 | 5.105 | 6.155 | 19.923 | -10.173 | -4.795 | 10.580 |
| Shareholders Funds | - | - | -5.397 | 12.432 | 12.683 | 16.004 | 21.264 | 23.919 | 21.920 | 12.827 |
| Social Capital | - | - | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | 25.560 | 25.467 | 20.530 | 8.952 | 8.609 | 28.255 | 20.600 | 34.495 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Neuroviva Srl